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Insulin and insulin-like growth factors (IGFs) elicit
distinct but overlapping biological effects in vivo. To
investigate whether differences in intrinsic signaling
capacity of receptors contribute to biological specific-
ity, we constructed chimeric receptors containing the
extracellular portion of the neurotrophin receptor TrkC
fused to the intracellular portion of the insulin or IGF-I
receptors. Chimeras were stably expressed in 3T3-L1
adipocytes at levels comparable to endogenous insulin
receptors and were efficiently activated by neurotro-
phin-3. The wild-type insulin receptor chimera medi-
ated approximately 2-fold greater phosphorylation of
insulin receptor substrate 1 (IRS-1), association of IRS-1
with phosphoinositide 3-kinase, stimulation of glucose
uptake, and GLUT4 translocation, compared with the
IGF-I receptor chimera. In contrast, the IGF-I receptor
chimera mediated more effective Shc phosphorylation,
association of Shc with Grb2, and activation of mitogen-
activated protein kinase compared with the insulin re-
ceptor chimera. The two receptors elicited similar acti-
vation of protein kinase B, p70S6 kinase, and glycogen
synthesis. We conclude that the insulin receptor medi-
ates some aspects of metabolic signaling in adipocytes
more effectively than the IGF-I receptor, as a conse-
quence of more efficient phosphorylation of IRS-1 and
greater recruitment/activation of phosphoinositide
3-kinase.
Insulin and insulin-like growth factors (IGFs)1 are structur-
ally related polypeptides that exert diverse effects on mamma-
lian tissues. The most prominent actions of insulin in vivo are
concerned with the acute regulation of carbohydrate and lipid
metabolism in liver, muscle, and fat, whereas IGFs act on
skeletal and other tissues to promote growth, differentiation,
and survival. The receptors for insulin and IGFs, which medi-
ate these effects (IR and IGFR), are also structurally related
and highly homologous, consisting of extracellular a-subunits
responsible for ligand binding and transmembrane b-subunits
possessing protein-tyrosine kinase activity, in a disulphide
linked b-a-a-b configuration (1–3). Within the intracellular
portion, the level of sequence identity between the receptors is
greatest in the tyrosine kinase domain (84%) and somewhat
less in the flanking juxtamembrane and carboxyl-terminal re-
gions (61 and 44%, respectively). Not surprisingly, the signal-
ing mechanisms of the insulin receptor (IR) and IGF-I receptor
(IGFR) are broadly similar. Ligand binding activates tyrosine
kinase activity, leading to phosphorylation of intracellular sub-
strates, such as IRS and Shc proteins, and the recruitment
and/or stimulation of signal transducing molecules, including
phosphoinositide 3-kinase (PI 3-kinase) and Grb2zSos (4, 5).
These signal transducers in turn promote activation of protein-
serine kinase cascades involving phosphoinositide-dependent
kinase/PKB and MAPK/Erk kinase/MAPK, respectively, which
modulate the activity of glucose transporters, enzymes, and
transcription factors (6, 7).
Given the similarity in structure and signaling mechanism of
the respective receptors, obvious questions arise concerning the
basis of specificity in the actions of insulin and IGFs in vivo. In
part, this specificity must reflect the different patterns of ex-
pression of receptors and responsive pathways in different cell
types. Indeed, when examined in the same cell background,
insulin and IGFs induce the same end point responses (8–10).
However, such studies do not rule out the possibility of subtle
differences in the coupling of the receptors to different re-
sponses, and there are various problems of interpretation in
making detailed comparisons of IR and IGFR activity in a given
cell type. First, neither receptor is completely specific for its
ligand, and at high ligand concentrations, some cross-reaction
with the heterologous receptor is inevitable. Second, it is diffi-
cult to make comparisons at equivalent occupancy of IR and
IGFR because of differences in ligand affinity and levels of
expression. Third, in cells that express both IR and IGFR a
substantial fraction of receptors assemble as hybrid structures
capable of binding both ligands (11). Finally, attempts to over-
come these problems by overexpression of receptors in trans-
fected cells might distort the signaling specificity, which could
be seen at lower and more physiological levels of receptor
expression.
In order to circumvent such problems, several laboratories
have made use of chimeric receptors, in which the intracellular
domains of the IR, IGFR, or insulin receptor-related receptor
are coupled to a common extracellular ligand binding domain
(12–15). It was reported that the IGFR was more efficient than
the IR in mediating stimulation of DNA synthesis in NIH3T3
fibroblasts, with no difference in stimulation of glucose uptake
(12). In contrast, in 3T3-L1 fibroblasts we found that the IR
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mediated a greater stimulation of glycogen synthesis compared
with the IGFR, with no difference in the extent or efficiency of
stimulation of DNA synthesis (14). Other work with truncated
receptors, site-directed mutants, and chimeras has suggested
that the efficiency of “metabolic” and “mitogenic” stimulations
may depend on the carboxyl-terminal domains of the respective
receptors (16–20), although the results have not been entirely
consistent (21). A serious limitation of all these studies is that
they have been carried out in cultured fibroblasts that display
only a limited range of rather small responses to insulin and
IGF-I compared with physiologically important target tissues.
We have therefore examined the question of intrinsic signaling
specificity by expressing IR and IGFR chimeras in differenti-
ated 3T3-L1 adipocytes, which are highly insulin-responsive.
We show here that glucose uptake is stimulated to a greater
extent by IR than IGFR and that differences in the relative
phosphorylation of distinct intracellular substrates by the IR
and IGFR tyrosine kinases contribute to signaling specificity of
the two receptors.
EXPERIMENTAL PROCEDURES
Materials—Antibodies were obtained from TCB (mouse monoclonal
anti-phosphotyrosine, 4G10), Sigma (mouse monoclonal anti-phospho-
tyrosine PY20), Promega (rabbit anti-ActiveTM MAPK) or New England
Biolabs (rabbit anti-phosphoAkt[Ser-473] and rabbit anti-pp70S6-ki-
nase[Thr-389]). Other antibodies were produced in-house in rabbits
using bacterially expressed GST fusion proteins as immunogens: anti-
IR-carboxyl-terminal (carboxyl-terminal 98 amino acids of human IR),
anti-IGFR-carboxyl-terminal (carboxyl-terminal 106 amino acids of hu-
man IGFR), anti-Shc (SH2-domain), anti-IRS-1 (carboxyl-terminal 236
amino acids of rat IRS-1), and anti-p85 (N-terminal SH2-domain). The
anti-Grb2 antibody (mouse monoclonal) was a gift from Dr. J. Schless-
inger (New York University Medical Center), rabbit anti-GLUT4 was a
gift from Prof. G. Gould (University of Glasgow), rabbit anti-GLUT1
was a gift from Prof. S. Baldwin (University of Leeds), and goat anti-
PKB and anti-p70S6 kinase antibodies were gifts from Dr. D. Alessi
(University of Dundee). The TrkC cDNA and Fra-1 cDNA probes were
gifts from Dr. J. M. Tavare´ (University of Bristol). NT-3 was generously
provided by Dr. E. Brewster (Regeneron Pharmaceuticals). Tissue cul-
ture media were purchased from Life Technologies, Inc., radiochemicals
from Amersham Pharmacia Biotech, restriction enzymes from New
England Biolabs, oligonucleotides from Genosys and other reagents
from Sigma.
Construction of Chimeras—Chimeras containing the extracellular
and transmembrane portions of the neurotrophin receptor TrkC to-
gether with the intracellular portion of the human IR (TIR) or IGFR
(TIGR) were constructed as described previously (14). The chimeras
were expressed under the regulation of the elongation factor 1a pro-
moter (a kind gift from Dr R. E. Lewis (Eppley Institute for Research in
Cancer, University of Nebraska)) in the vector pcDNA3 (Invitrogen).
Tissue Culture—3T3-L1 fibroblasts (ATCC) were maintained at no
higher than 70% confluency in DMEM containing 10% newborn calf
serum, 4.5 g/liter glucose, 2 mM glutamine, and antibiotics (DMEM/
newborn calf serum). For differentiation they were grown 2 days post-
confluency in the same medium and then for 2 days in medium con-
taining fetal calf serum instead of newborn calf serum (DMEM/fetal calf
serum) supplemented with insulin (5 mg/ml), dexamethasone (0.1 mg/
ml), and isobutylmethylxanthine (110 mg/ml), for 2 days in DMEM/fetal
calf serum with insulin only and finally for 6 days in DMEM/fetal calf
serum. Differentiated cells were used only when at least 90% of the cells
showed adipocyte phenotype by accumulation of lipid droplets. 3T3-L1
fibroblasts were transfected using LipofectAMINETM reagent (Life
Technologies, Inc.) and selected in medium containing 600 mg/ml G418
(Life Technologies, Inc.) to produce stable expressing clones (obtained
by subculturing at limiting dilution on microtitre plates).
NT-3 Binding—The expression levels of the chimeras in 3T3-L1 cells
were analyzed by radioligand binding assay. NT-3 was radioiodinated
as described (14). The cells were incubated with 125I-NT-3 (30,000 dpm)
and increasing concentrations of unlabeled NT-3 in binding buffer (100
mM Hepes, 120 mM NaCl, 1 mM EDTA, 15 mM NaC2H4O2) overnight at
4 °C, washed twice in cold phosphate-buffered saline, solubilized in 0.1
M NaOH and counted in a NE1600 gamma counter. IC50 values were
obtained from calculations with GraphPad PRISM, version 2.01.
Western Blotting—Serum-starved adipocytes were stimulated for 5
min and solubilized in lysis buffer (50 mM Hepes, 150 mM NaCl, 1 mM
EDTA, 30 mM NaF, 1% Triton X-100, 1 mM Na3VO4, 10 mM Na2P2O7,
0.1 mM 4-(2-aminoethyl)benzene sulfonyl fluoride, HCl, 2.5 mM benza-
midine, 1 mg/ml antipain, 1 mg/ml leupeptin, 1 mg/ml pepstatin A), and
the lysate was clarified by centrifugation at 13,500 3 g for 15 min at
4 °C. Lysates were subjected to immunoprecipitation using anti-IRS-1
(1:200) or anti-Shc (1:200) antibodies plus protein A-agarose (2 mg/
sample), and immunoprecipitates were washed once in lysis buffer and
twice in phosphate-buffered saline on ice. Crude cell extracts or specific
immunoprecipitates were resolved by SDS-PAGE before electroblotting
to polyvinylidene difluoride membranes (Millipore), and specific pro-
teins were detected by incubation with appropriate antibodies in TBST
(150 mM NaCl, 50 mM Tris, 0.1% Tween 20) after blocking in 1% bovine
serum albumin, followed by 125I-labeled secondary antibodies (approx-
imately 0.2 mCi per blot), and quantified on a Fujix BAS2000
phosphorimager.
Glucose Uptake—Assays were performed as described previously
(22). In short, differentiated adipocytes in six-well plates were serum-
starved for 2 h in DMEM containing 25 mM glucose and 2 mM glutamine
and incubated in 1 ml of KRH (136 mM NaCl, 4.7 mM KCl, 1.25 mM
CaCl2, 1.25 mM MgSO4, 10 mM Hepes, pH 7.4) with hormone at 37 °C
for 30 min and 2-deoxy-D-[2,6-3H]glucose (0.33 mCi/ml; final specific
activity, 6.7 mCi/mmol) for an additional 5 min. Uptake was stopped by
three rapid washes on ice with KRH, the cells were solubilized in 1 ml
of 0.1 M NaOH and neutralized (50 ml of concentrated HCl), and radio-
activity was determined by liquid scintillation counting.
Plasma Membrane Lawn Assays of GLUT4 Translocation—3T3-L1
adipocytes, grown on collagen-coated glass coverslips, were serum-
starved for 2 h. Cells were either left untreated or stimulated for 15 min
with 100 nM insulin or 4 nM NT-3. Coverslips were rapidly washed in
ice-cold buffer for the preparation of plasma membrane lawns exactly as
described (23). After fixation in paraformaldehyde, plasma membrane
lawns were incubated with either anti-GLUT4 or anti-GLUT1 antibody
(1:100 dilution) for 2 h at room temperature. After washing, the cover-
slips were incubated with fluorescein isothiocyanate-conjugated donkey
anti-rabbit IgG, washed, and mounted on glass slides. Coverslips were
viewed using a 3 60 objective lens on a Nikon Optiphot-2/Bio-Rad
MRC-1000 microscope operated in laser scanning confocal mode. Sam-
ples were illuminated at 488 nm, and images were collected at 510 nm.
Duplicate coverslips were prepared at each experimental condition, and
five random images of plasma membrane lawn were collected from
each. Five fields from each image were quantified using Bio-Rad MRC-
1000 confocal microscope operating software (CoMOS, version 6.05.8),
on an AST premmia SE P/60 personal computer.
Glycogen Synthesis—Assays were performed as described previously
(24). In short, fully differentiated adipocytes in six-well plates were
serum-starved for 3 h in DMEM with 5.5 mM glucose and 2 mM gluta-
mine, stimulated with hormone for 30 min, and incubated with D-[U-
14C]glucose (1 mCi/ml; final specific activity, 0.18 mCi/mmol) for 30 min.
Incubations were stopped by three rapid washes on ice with phosphate-
buffered saline, the cells were solubilized in 1 ml of 0.1 M NaOH, carrier
glycogen was added (2 mg), and the samples were boiled for 30 min.
Glycogen was precipitated with 70% ethanol overnight at 220 °C; the
samples were centrifuged at 1720 3 g, washed once with 70% ethanol,
and resuspended in water; and radioactivity was determined by scin-
tillation counting.
Glycogen Synthase Activity Assay—Assays were performed as de-
scribed (25). In short, differentiated adipocytes in six-well plates were
starved for 3 h in serum-free DMEM without glucose supplemented
with 20 mM Hepes and 1% bovine serum albumin, incubated with
hormone for 30 min, washed in 100 mM NaF-10 mM EDTA, scraped off,
and sonicated. The enzyme activity was determined in a Tris (50 mM),
NaF (25 mM), EDTA (20 mM) buffer with glycogen (10 mg/ml) and
uridine-59-diphospho-D-[U-14C]glucose (5 mCi/ml; final specific activity,
1.3 mCi/mg) and in the absence or presence of glucose 6-phosphate (2
mg/ml) for 20 min at 30 °C. The samples were spotted on filter paper
and washed three times in 70% ethanol and dried, and radioactivity
was determined by liquid scintillation counting. Activity was calculated
as a percentage of the maximum: that is, 100 3 (activity without
glucose 6-phosphate)/(activity with glucose 6-phosphate).
Phosphoinositide 3-Kinase Assay—Cells were stimulated for 5 min,
lysed, and immunoprecipitated with either anti-IRS-1 (1:200) or anti-
phosphotyrosine PY20 (1:50) antibody. The immunoprecipitates were
washed and assayed as previously described (26). In short, the immu-
noprecipitates were incubated with phosphatidylinositol and [32P]ATP
for 15 min at 37 °C, and the reaction was stopped with chloroform:
methanol (1:2). The lipids were extracted twice by acidic chloroform
extraction, and the lower phase was collected and dried in a speed-
vacuum drier. The lipid film was resuspended and spotted on TLC
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plates (kieselgel 60F254 from Merck) and run in chloroform:meth-
anol:ammonia:water (300:210:45:75 (v/v)). The resolved radiolabeled
phosphatidylinositol 3-phosphate was quantified on a Fujix BAS2000
phosphorimager.
PKB Kinase Activity—The assay was performed as described (27).
Cells were serum-starved overnight, stimulated with hormone for 5
min, and extracted in PKB lysis buffer (50 mM Tris, 1 mM EDTA, 1 mM
EGTA, 1% Triton X-100, 1 mM sodium orthovanadate, 50 mM NaF, 5 mM
pyrophosphate, 0.27 M sucrose, 1 mM microcystin, 0.1% b-mercaptoeth-
anol, protease inhibitors). The extracts (250 mg) were immunoprecipi-
tated with PKB-b-specific antibody followed by PKB-a-specific antibody
or PKB-g-specific antibody (all at 5 mg/sample) and protein G-Sepha-
rose (2 mg), and the precipitates were washed twice in lysis buffer with
0.5 M NaCl and once in Buffer A (50 mM Tris, 0.1 mM EGTA, 0.1%
b-mercaptoethanol). The kinase activity was measured against cross-
tide substrate in assay buffer (50 mM Tris, 0.1 mM EGTA, 2.5 mM PKI,
0.1 mM ATP, 10 mM MgCl2, 300 mM cross-tide) with [
32P]ATP (0.3
mCi/sample) for 30 min at 30 °C. Incubations were stopped by spotting
on p81 Whatman filter paper and washing in phosphoric acid (85 mM);
the papers were washed three additional times, dipped in acetone, and
dried; and radioactivity was determined by scintillation counting.
Phosphorylation of PKB, p70S6-Kinase, and MAP Kinase—The ser-
ine phosphorylation of PKB/Akt (a- and b-isoforms) after 5 min of
stimulation was determined by Western blotting (as described above)
with antibody specific for the phosphorylated (Ser-473) form of the
enzyme (rabbit anti-phosphoAkt[Ser473] from Upstate Biotechnology,
Inc.). The phosphorylation of MAPK was similarly determined by blot-
ting with an antibody specific for the doubly phosphorylated (Thr/Tyr)
form of the enzyme (rabbit anti-ActiveTM MAPK from Promega). The
phosphorylation of p70S6-kinase after 15 min of stimulation was deter-
mined by immunoprecipitation of clarified lysates with goat-anti-
p70S6-kinase (1 mg/sample) and protein G-agarose (20 mg/sample), fol-
lowed by SDS-PAGE and Western blotting with an antibody specific for
the phosphorylated form of the enzyme (rabbit anti-pp70S6-kinase[Thr-
389] from New England Biolabs). Blotting data were quantified on a
Fujix BAS2000 phosphorimager.
Induction of Fra-1 mRNA—Fully differentiated 3T3-L1 adipocytes
were serum-starved overnight and stimulated for 4 h with hormone,
and RNA was extracted with TriReagent (Sigma). Northern blots were
performed as described (28), transferred to HybondTM N membrane
(Amersham Pharmacia Biotech), and cross-linked by UV irradiation.
Probe for Fra-1 (generously provided by Dr. J. M. Tavare´, University of
Bristol) was labeled according to the protocol with [32P]CTP using
Rediprime labeling system (Amersham Pharmacia Biotech) and puri-
fied on NickTM columns (Amersham Pharmacia Biotech). The mem-
branes were incubated in QuickHyb (Stratagene) for 1 h at 68 °C with
the boiled probe and washed twice in 23 SSC (13 SSC: 0.15 M NaCl, 15
mM sodium citrate) with 0.1% SDS at room temperature and twice in
0.53 SSC with 0.1% SDS at 65 °C. The later samples were analyzed by
dot blots after verification of the probe specificity on Northern blots.
The results were quantified on a Fujix BAS2000 phosphorimager.
RESULTS
Expression of TIR and TIGR Constructs—Chimeric con-
structs containing the intracellular portions of the IR or IGFR
together with the extracellular portion of the TrkC receptor
(TIR and TIGR, respectively) were expressed in 3T3-L1 cells
under the control of the elongation factor 1a promoter, which
was found to drive similar levels of expression in both fibro-
blasts and adipocytes. Clonal lines of transfected fibroblasts
were selected with G418 and screened for expression of chime-
ras by Western blotting cell extracts with anti-IR and anti-
IGFR antibodies as appropriate, no suitable anti-TrkC anti-
body being available. Following differentiation into adipocytes,
clones were rescreened by Western blotting of extracts with
anti-phosphotyrosine antibodies after stimulation with NT-3 or
insulin. Two clones were selected for further study that ex-
pressed similar levels of TIR and TIGR, as judged by relative
intensity of NT-3-stimulated autophosphorylation in adipo-
cytes (Fig. 1 and Table I). The levels of expression were repro-
ducible on repeated differentiation of adipocytes from fibro-
blast stocks. The levels of expression of chimeras were
approximately 2-fold (Table I) higher than those of endogenous
insulin receptors, as judged by Western blotting with anti-IR
and/or anti-phosphotyrosine antibodies after stimulation with
NT-3 or insulin. By the same criteria, the levels of endogenous
insulin receptors were identical in both clones. There was no
evidence of cross-phosphorylation of chimeras following stimu-
lation with insulin or of insulin receptors following stimulation
with NT-3. Radioligand binding assays were carried out on the
selected clones to verify that the chimeras bound NT-3 with an
affinity comparable to the wild-type TrkC (Fig. 1C). There was
no detectable binding of NT-3 to untransfected adipocytes.
FIG. 1. Expression of chimeras in 3T3-L1 adipocytes. A, anti-
phosphotyrosine Western blotting. Serum-starved cells were stimu-
lated for 5 min with 4 nM NT-3 (N) or 10 nM insulin (I) or left unstimu-
lated (O) and lysed, and 100 mg of protein from each lysate was
subjected to SDS-PAGE in duplicate and immunoblotted with anti-
phosphotyrosine antibody (4G10). B, time course of receptor autophos-
phorylation. Anti-phosphotyrosine blots obtained as in A were quanti-
fied by phosphorimaging. C, NT-3 binding. Cells grown in 24-well plates
were incubated in duplicate with 125I-NT-3 and the indicated concen-
trations of unlabeled NT-3 at 4 °C overnight and washed, and bound
radioactivity was counted. Filled circles, TIR; open circles, TIGR; trian-
gles, untransfected 3T3 L1 adipocytes; crosses, TrkC-transfected CHO
cells (MG86). Estimated IC50 values are as follows: TIR, 0.14 nM; TIGR,
0.10 nM; TrkC, 0.14 nM.
TABLE I
Receptor levels in 3T3-L1 adipocytes of chimeric expressing clones
Lysates from clonal cell lines that had been stimulated with 10 nM
insulin or 4 nM NT-3, containing equivalent amounts of protein, were
subjected to SDS-PAGE and Western blotting.
Cell line Phospho-IRlevelsa
Phospho-chimera
levelsb IR levels
c
TIR 0.7 1 0.8
TIGR 0.7 1.7
a Insulin receptor phosphorylation in response to insulin relative to
TIR phosphorylation in response to NT-3, assessed by Western blotting
with anti-phosphotyrosine antibody.
b Chimera phosphorylation in response to NT-3 relative to TIR phos-
phorylation levels, assessed by Western blotting with anti-phosphoty-
rosine antibody.
c Insulin receptor levels relative to TIR levels, assessed by Western
blotting with insulin receptor-specific antibody. Data shown are mean
values from three independent determinations in all cases.
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Metabolic Responses in 3T3-L1 Adipocytes—Previous work
on 3T3-L1 fibroblasts had shown that TIR mediated a greater
stimulation of glycogen synthesis than TIGR, although the
magnitude of response to NT-3 or insulin in these cells was
relatively small (14). The present studies were conducted with
an independently derived set of clones, in which expression of
chimeras was under the control of a different promoter from
that used previously. We tested metabolic responses following
stimulation of TrkC chimeras in 3T3-L1 adipocytes, which ex-
press the GLUT4 glucose transporter and are much more in-
sulin-responsive than fibroblasts.
Glucose uptake was stimulated similarly (typically 6–8-fold)
by 10 nM-insulin in both clones of transfected cells. However,
when cells were treated with NT-3, stimulation of glucose up-
take was consistently 2-fold greater via TIR than via TIGR, at
all concentrations of NT-3 (Fig. 2A). There was no detectable
response to NT-3 in untransfected cells.
To confirm that the stimulation of glucose uptake by the two
chimeras reflected primarily the translocation of GLUT4 glu-
cose transporters to the plasma membrane, we performed
plasma membrane lawn assays. Plasma membrane lawns from
disrupted cells were probed with anti-GLUT4 or GLUT1 anti-
body followed by immunofluorescence detection (Fig. 3). In all
cell lines (TIR, TIGR, and untransfected), insulin induced 4–5-
fold increases in GLUT4 immunostaining, but only 1.5–2-fold
increases in GLUT1 immunostaining. In agreement with the
results on glucose uptake, the TIR chimera mediated a signif-
icantly greater increase in GLUT4 at the plasma membrane
than the TIGR chimera (Fig. 3B). There was no effect of NT-3
on GLUT4 distribution in untransfected cells lacking chimera.
Similar trends were apparent for the translocation of GLUT1
in TIR and TIGR cells, although the small magnitude of stim-
ulations made it difficult to draw clear conclusions in this case.
Incorporation of glucose into glycogen was stimulated ap-
proximately 15-fold by insulin in both clones. Maximum stim-
ulation of glycogen synthesis and glycogen synthase by 4 nM
NT-3 was similar in TIR and TIGR cells (Fig. 2, B and C), but
TIR cells responded significantly better than TIGR at submaxi-
mal NT-3 concentrations (Fig. 2B). Again, stimulation of gly-
cogen synthesis by NT-3 was undetectable in untransfected
cells. The fact that the difference in maximum stimulation of
glucose uptake by NT-3 in TIR and TIGR cells was not reflected
in differential maximal stimulation of glucose incorporation
into glycogen suggests that glycogen synthase activity, rather
than glucose transport, was rate-limiting for glycogen synthe-
sis under these conditions. Consistent with this hypothesis, gly-
cogen synthesis was near maximally stimulated at concentra-
tions of NT-3 that produced little stimulation of glucose uptake.
Moreover, glycogen synthesis was similarly more sensitive than
glucose uptake to stimulation by insulin (data not shown).
Phosphorylation of Intracellular Substrates—The initial step
in signal transduction from the IR and IGFR is the tyrosine
phosphorylation of intracellular substrates, such as IRS and
Shc proteins, which then recruit other signaling intermediates,
such as PI 3-kinase and Grb2zSos, respectively (4, 29). Substan-
tial evidence implicates the PI 3-kinase pathway as an essen-
tial component of signaling to glucose transport and glycogen
synthesis (30), whereas Grb2zSos is required for activation of
the MAP kinase pathway (7). To examine whether the differ-
ences in metabolic responses mediated by TIR and TIGR in
3T3-L1 adipocytes were a consequence of differential activation
of known signaling pathways, we used sequential immunopre-
cipitation and Western blotting to determine the tyrosine phos-
phorylation of IRS-1 and Shc and the association of these
proteins with the p85 regulatory subunit of PI 3-kinase and
Grb2, respectively (Fig. 4). Data were normalized by expression
as a percentage of signals obtained following stimulation with
10 nM insulin, which produced similar responses in both clonal
lines.
FIG. 2. Stimulation of glucose uptake and glycogen synthesis.
A, 2-deoxy-glucose uptake. Cells grown in six-well plates were serum-
starved for 2 h and stimulated for 30 min with the indicated concen-
trations of NT-3 (O, unstimulated; N, 4 nM NT-3) before measurement
of 2-deoxyglucose uptake over 5 min as described under “Experimental
Procedures.” Data are means 6 SD from three (dose-response) or five
(inserted bars) independent experiments performed in duplicate, nor-
malized to stimulation with 10 nM-insulin (mean insulin responses,
3635 cpm/well for TIR and 4265 cpm/well for TIGR). Filled circles and
filled columns, TIR; open circles and open columns, TIGR (*p , 0.05,
TIR versus TIGR). B, glycogen synthesis. Cells grown in six-well plates
were serum-starved for 3 h and stimulated for 30 min with the indi-
cated concentrations of NT-3 (O, unstimulated; N, 4 nM NT-3) before
measurement of [14C]glucose incorporation into glycogen over 90 min as
described under “Experimental Procedures.” Data are means 6 SD
from three (data points) or five (columns) independent experiments
performed in duplicate, normalized to stimulation with 10 nM-insulin
(mean insulin responses, 18,450 cpm/well for TIR and 18,900 cpm/well
for TIGR). Symbols as in A. C, glycogen synthase activity. Cells grown
in six-well plates were serum-starved for 3 h and stimulated for 30 min
without (hatched columns) or with (gray columns) NT-3 (4 nM) before
measurement of glycogen synthase fractional activity (with or without
glucose 6-phosphate) as described under “Experimental Procedures.”
Data are means 6 SD from six (TIR) or three (TIGR) independent
experiments performed in duplicate, normalized to activity with 10
nM-insulin (mean insulin responses, 11.7% in TIR and 9.85% in TIGR).
Differences between values for TIR and corresponding values for TIGR
were not significant (p . 0.1).
Insulin and IGF Receptor Signaling in Adipocytes 30867
 at UQ Library on October 19, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
The level of IRS-1 tyrosine phosphorylation induced by NT-3
after 5 min was approximately 2-fold higher in TIR cells com-
pared with TIGR, at all concentrations (Fig. 4A). It was con-
firmed by stripping and reprobing blots with anti-IRS antibody
that equal amounts of IRS-1 were immunoprecipitated from
TIR and TIGR cells. The level of p85 in the same IRS-1 immu-
noprecipitates was higher in TIR cells than TIGR, although the
basal was also higher (Fig. 4B). The differences in stimulation
of IRS-1 phosphorylation and p85 association were maintained
throughout the 30-min period used to measure glucose uptake
(Fig. 5). Thus, the relative NT-3-induced IRS-1 phosphoryla-
tion and p85 association mediated by TIR and TIGR closely
paralleled stimulation of glucose uptake.
In contrast, NT-3-induced tyrosine phosphorylation of the
52-kDa isoform of Shc, and its association with Grb2, were each
approximately 2.5-fold higher in TIGR cells compared with TIR
(Fig. 4, C and D). Weak stimulation of phosphorylation of the
66-kDa isoform of Shc was seen in TIGR but not TIR cells
(Fig. 4C).
Activation of Phosphoinositide 3-Kinase—We next examined
whether differences in p85 association with IRS-1 were paral-
leled by differences in PI 3-kinase activity in anti-IRS-1, anti-
phosphotyrosine, and anti-p85 immunoprecipitates. There was
no stimulation of PI 3-kinase activity by NT-3 in anti-IRS-1 or
anti-phosphotyrosine immunoprecipitates in untransfected
cells. Activity of PI 3-kinase in anti-IRS-1 immunoprecipitates
was approximately 70% greater in TIR cells than in TIGR cells
following NT-3 stimulation (Fig. 6A). As with the other differ-
ential responses, the maximum stimulation by NT-3 was some-
what greater than that with 10 nM insulin in TIR cells, but
appreciably less in TIGR cells. No significant difference was
observed in the PI 3-kinase activities in anti-phosphotyrosine
precipitates from NT-3-stimulated TIR and TIGR cells (Fig.
6B). The maximum activity in response to NT-3 was very
similar to the response to 10 nM insulin in both cell lines and
approximately 30% of the maximum PI 3-kinase activity ob-
served in anti-IRS-1 immunoprecipitates. As previously ob-
served (26), PI 3-kinase activity in anti-p85 precipitates was
not significantly stimulated by insulin, nor was it stimulated
by NT-3, but the activities measured were the same in TIR and
TIGR cells (data not shown). Only approximately 20% of the
p85 precipitable PI 3-kinase activity was recovered in IRS-1
precipitates from insulin-stimulated TIGR cells.
Activation of Akt/PKB—Recent evidence has indicated that
signaling downstream from PI 3-kinase involves translocation
and/or activation of one or more phosphoinositide-dependent
kinases, which in turn phosphorylate and activate Akt/PKB, a
serine/threonine-specific protein kinase that exists in three
isoforms a, b, and g (6). The three isoforms were present at
similar levels in 3T3-L1 adipocytes, as reflected in the basal or
insulin-stimulated kinase activity measured in specific immu-
noprecipitates (Fig. 7). In both TIR and TIGR-expressing cells,
NT-3 (4 nM) induced levels of kinase activity of all three iso-
forms that were approximately the same as those induced by
insulin (10 nM) (all 2–3 fold over basal), with no significant
difference between the two chimeras. We also assessed the
phosphorylation of Ser-473 of PKB (a- and b-isoforms) by West-
ern blotting with phosphopeptide-specific antibody, as an index
of stimulation (6). Again, NT-3 and insulin induced similar
levels of phosphorylation (6-fold over basal), with no significant
difference between TIR or TIGR cells at either 5 or 30 min of
stimulation (Fig. 8A).
Phosphorylation of p70S6 Kinase—Activation of p70S6 ki-
nase is, like the activation of PKB, dependent on PI 3-kinase
(30). Stimulation of glucose transport by insulin is clearly in-
dependent of p70S6 kinase activity, but the enzyme may play a
role in the activation of glycogen synthase in some cell types
including 3T3-L1 adipocytes (31). Activation of p70S6 kinase by
growth factors is associated with phosphorylation at multiple
sites, of which Thr-412 in the mouse enzyme (corresponding to
Thr-389 in the human enzyme) correlates most closely with
activity (32). We used a phospho-specific antibody to determine
phosphorylation of p70S6 kinase in TIR or TIGR cells after 15
min of stimulation with NT-3 or insulin (Fig. 8B). The two
chimeras were equally effective in mediating p70S6 kinase
phosphorylation, at both submaximal and maximal concentra-
tions of NT-3, and the stimulation at the higher concentration
of NT-3 was very similar to that induced by insulin.
Phosphorylation of MAP Kinase—Tyrosine phosphorylation
of Shc and its association with the Grb2zSos complex is a major
pathway leading via Ras, Raf, and MAPK/Erk kinase to the
phosphorylation and activation of MAP kinase (7). This path-
way has been implicated in signaling to transcriptional and
mitogenic events, but it appears not to be important in regu-
lating acute metabolic responses (7). We investigated the ac-
tivity of MAP kinase by immunoblotting cell extracts with an
antibody specific for the doubly (Thr/Tyr) phosphorylated and
hence activated form of the enzyme (33). In 3T3-L1 cells, the
p42 isoform of MAP kinase was more abundant than p44 iso-
form, as judged by immunoblotting with a pan-specific anti-
MAP kinase antibody, or with anti-phospho-MAP kinase in
stimulated cells (data not shown). Phosphorylation of p42MAPK
in response to a maximally effective concentration of NT-3 (4
nM) was consistently and significantly greater in TIGR cells
FIG. 3. Plasma membrane lawn assay of GLUT4 and GLUT1
translocation. Serum-starved 3T3-L1 adipocytes were either left un-
treated (O) or stimulated with 100 nM insulin or 4 nM NT-3 (N) for 15
min before preparation of plasma membrane lawns and assay of glucose
transporter translocation. Data from each experiment, utilizing 50
fields for each condition, were quantified as described under “Experi-
mental Procedures.” A, representative images from a typical experi-
ment. B, GLUT4 at plasma membrane (PM), calculated as mean 6 S.E.
fold increase over basal for three (wild-type untransfected 3T3-L1 adi-
pocytes (WT)), five (TIR), and four (TIGR) independent experiments. C,
GLUT1 at plasma membrane, calculated as mean 6 S.E. fold increase
over basal for three independent experiments. Statistically significant
differences between responses to NT-3 in TIR and TIGR cells are
indicated.
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than in TIR cells (Fig. 8C). The response to NT-3 in TIGR cells
was also greater than the response to insulin. Similar differ-
ences were evident with p44MAPK (data not shown).
Induction of Fra-1 mRNA—Fos-related antigen 1 (Fra-1) is a
nontransforming Fos analogue involved in G0 to G1 transition
and asynchronous cell growth. Fra-1 mRNA is induced by in-
sulin or serum (34). Because measurement of mitogenesis/DNA
synthesis is not meaningful in terminally differentiated 3T3-L1
cells, which do not divide, we used induction of Fra-1 mRNA as
an alternative end point readout of the MAPK pathway. We
found no difference between TIR or TIGR cells, both of which
showed 4–5-fold induction of Fra-1 mRNA after 4 h of incuba-
tion with 4 nM NT-3, similar to the response to 10 nM insulin
(data not shown).
DISCUSSION
Although insulin and IGFs exert distinct physiological ef-
fects in vivo, the contribution of differences in receptor func-
tion, as opposed to receptor distribution, to this specificity
remains unclear. Functional differences might arise from the
kinetics of ligand association and dissociation, affecting the
lifetime and/or intracellular itinerary of the activated receptors
(35, 36). Alternatively, the receptor intracellular domains
FIG. 5. Persistence of IRS-1 phosphorylation and p85 associa-
tion. IRS-1 tyrosine phosphorylation and association with p85 were
determined after 30 min of incubation without (0) or with (N) 4 nM
NT-3, as described in legend to Fig. 4. Data were calculated relative to
the effect of 10 nM insulin for three independent experiments, as in Fig.
4. Filled columns, TIR; open columns, TIGR.
FIG. 4. Phosphorylation and SH2-association of IRS-1 and Shc. A, IRS-1 tyrosine phosphorylation. Serum-starved cells were stimulated
for 5 min with NT-3 or insulin as indicated and lysed, and 500 mg of protein was immunoprecipitated with anti-IRS-1 antibody and subjected to
SDS-PAGE and immunoblotting with anti-phosphotyrosine antibody. A representative gel is shown with each data set, and numerical data shown
are means 6 SD obtained by quantification of gels from three independent experiments performed in duplicate, normalized to stimulation with 10
nM insulin (mean insulin responses, 110 arbitrary phosphorimager units for TIR and 145 units for TIGR). Filled circles, TIR; open circles, TIGR;
*p , 0.05, TIR versus TIGR. B, IRS-1 association with p85 regulatory subunit of PI 3-kinase. Lysates from stimulated cells were prepared,
immunoprecipitated and electrophoresed as in A before immunoblotting with anti-p85 antibody. Data presentation is as in A (mean insulin
responses, 320 arbitrary phosphorimager units in TIR and 400 units in TIGR). C, Shc tyrosine phosphorylation. Lysates from stimulated cells were
prepared as in A, immunoprecipitated with anti-Shc antibody, and electrophoresed and immunoblotted with anti-phosphotyrosine antibody. Data
presentation is as in A (mean insulin responses, 174 arbitrary phosphorimager units in TIR and 144 units in TIGR). D, Shc association with Grb2.
Lysates from stimulated cells were prepared, immunoprecipitated, and electrophoresed as in C before immunoblotting with anti-Grb2 antibody.
Data presentation is as in A (mean insulin responses, 515 arbitrary phosphorimager units in TIR and 450 units in TIGR).
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might possess different signaling capacities, reflecting their
differences in primary sequence (nonidentity, 16% in the tyro-
sine kinase domain, 39% in the juxtamembrane domain, and
56% in the carboxyl-terminal domain). To focus on the activity
of intracellular domains without interference from endogenous
receptors and to allow examination of a range of physiologically
relevant metabolic responses, we expressed TrkC-IR (TIR) or
TrkC-IGFR (TIGR) chimeras in 3T3-L1 adipocytes. Signaling
capacities of the IR and IGFR have previously been compared
only in transfected fibroblasts, in which reaction of ligands
with endogenous as well as transfected receptors complicates
interpretation of data, and the spectrum and magnitude of
metabolic responses are rather small; the results of such stud-
ies have been inconsistent. For instance, it was reported that
the IGFR was more effective than the IR in stimulating DNA
synthesis and MAP kinase activity (12, 37), although in other
work, no such difference was observed (14, 38). The IR ap-
peared to be more effective than IGFR in phosphorylating
IRS-1 and activating PI 3-kinase in one study (38) but not in
another (39).
We found that stimulation of glucose uptake and GLUT4
FIG. 6. Activation of PI 3-kinase. A, PI 3-kinase activity in anti-
IRS-1 immunoprecipitates. Serum-starved cells were stimulated for 5
min with NT-3 as indicated (O, unstimulated; N, 4 nM NT-3) and lysed,
and 100 mg of protein was immunoprecipitated with anti-IRS-1 anti-
body before measurement of PI 3-kinase activity as described under
“Experimental Procedures.” Data are means 6 range/SD from two (data
points) or four (columns) independent experiments performed in dupli-
cate, normalized to stimulation with 10 nM-insulin (mean insulin re-
sponses, 1130 arbitrary phosphorimager units in TIR and 1280 units in
TIGR). Filled circles and filled columns, TIR; open circles and open
columns, TIGR; (*p , 0.05, TIR versus TIGR). B, PI 3-kinase activity in
anti-phosphotyrosine immunoprecipitates. Cells were treated and ex-
tracted as in A except that immunoprecipitation was carried out with
anti-phosphotyrosine antibody prior to determination of PI 3-kinase
activity. Data presentation and symbols are as in A (mean insulin
responses, 450 arbitrary phosphorimager units in TIR and 390 units in
TIGR).
FIG. 7. Activation of protein kinase B. Serum-starved cells were
stimulated for 5 min with 4 nM NT-3 (N) or 10 nM insulin (I) or left
unstimulated (O) and lysed, and 200 mg of protein from each lysate was
immunoprecipitated with antibodies specific for the a-, b-, or g-isoform
of PKB before assaying PKB activity as described under “Experimental
Procedures.” Data are means 6 SD from three independent experi-
ments performed in duplicate, normalized to stimulation of the a-iso-
form with 10 nM-insulin (a, 494 cpm/mg protein in TIR and 398 in
TIGR). Filled columns, TIR; open columns, TIGR.
FIG. 8. Phosphorylation of PKB, p70S6 kinase, and MAP ki-
nase. A, phosphorylation of PKB on Ser-473. Serum-starved cells were
stimulated for 5 or 30 min as in Fig. 7, and lysates were subjected to
SDS-PAGE and immunoblotted with antibody specific for the phospho-
S473 form of PKB (isoforms a and b). Data are means 6 SD from three
independent experiments performed in duplicate, normalized to stim-
ulation with 10 nM-insulin. B, phosphorylation of p70S6-kinase on
Thr-389. Serum-starved cells were stimulated for 15 min as indicated,
and lysates were immunoprecipitated with anti-p70S6-kinase antibody,
subjected to SDS-PAGE, and immunoblotted with antibody specific for
the phospho-Thr 389 form of the p70S6 kinase. Data are means 6 SD
from four independent experiments performed in duplicate, normalized
to stimulation with 10 nM-insulin. C, phosphorylation of 42-kDa MAPK.
Serum-starved cells were stimulated for 5 min with NT-3 as indicated,
and lysates were subjected to SDS-PAGE and immunoblotted with
antibody specific for the doubly (Thr/Tyr) phosphorylated form of
MAPK. Data are mean 6 range from two independent experiments
performed in duplicate, normalized to stimulation with 10 nM-insulin
(**p , 0.005 TIGR versus TIR). In all panels, filled columns represent
TIR, and open columns represent TIGR.
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translocation in 3T3-L1 adipocytes was more effectively medi-
ated by TIR than TIGR (Figs. 2 and 3). TIR also mediated
greater stimulation of IRS-1 phosphorylation and IRS-1-asso-
ciated PI 3-kinase activity at both early and late time points
(Figs. 4–6). These differences were consistently observed when
paired clones of 3T3-L1 fibroblasts, selected for similar levels of
expression of TIR and TIGR, were differentiated on multiple
occasions. The differences were not a consequence of unequal or
excessive expression of the respective chimeras, as if anything,
the TIGR was expressed at a slightly higher level than TIR in
the differentiated adipocytes, and the level of expression of
both chimeras was of the same order as that of endogenous
insulin receptors. We also rule out the possibility that the
different responses of TIR and TIGR cells to NT-3 reflect
chance clonal variation, as insulin acting via its own receptor
elicited very similar responses in both sets of cells. Moreover,
phosphorylation of Shc showed the opposite relationship to
phosphorylation of IRS-1 in the same cells, being more effec-
tively induced via the TIGR than via TIR (Fig. 4).
The more effective stimulation of glucose uptake via the IR
than the IGFR chimera was manifest as a difference in maxi-
mum response rather than half-maximally effective concentra-
tion of NT-3 (EC50 approximately 0.2 nM), although the dose-
response relationships were not defined with sufficient
precision to rule out a difference in sensitivity. It is generally
believed that glucose uptake reflects the number of GLUT4
transporters at the plasma membrane (29), and we showed that
the translocation of GLUT4 was indeed greater in response to
stimulation of TIR than TIGR (Fig. 3). This result implies that
the IR signals to a larger intracellular pool of transporters than
the IGFR, which might reflect differential efficiency of mobili-
zation from a single pool of transporters, or differential recruit-
ment from more than one pool. In relation to the latter possi-
bility, it has been shown that GLUT4 vesicles cycle through
several distinct intracellular compartments in adipocytes (40),
and in skeletal muscle, discrete pools of GLUT4 vesicles are
responsive to stimulation by insulin and contraction (41).
There is ample evidence that PI 3-kinase activity is both
necessary and sufficient for stimulation of glucose transport
(29, 30). Differences in glucose uptake and GLUT4 transloca-
tion mediated by TIR and TIGR were paralleled by greater
IRS-1-associated PI 3-kinase activity, and the stimulations of
glucose uptake and IRS-1 phosphorylation showed similar
NT-3 concentration dependence (EC50 approximately 0.2 nM)
(Figs. 2–4). In contrast, TIR and TIGR induced similar PI
3-kinase activity measured in anti-phosphotyrosine precipi-
tates, and this activity was increased at very low concentra-
tions of NT-3 (,0.04 nM). Our finding that relative stimulations
of glucose transport correlate better with IRS-associated than
with anti-phosphotyrosine-precipitable PI 3-kinase activity are
at variance with studies suggesting that IRS-1-associated PI
3-kinase was not essential for glucose transport stimulation
(42, 43).
The serine-specific protein kinase PKB/Akt has been identi-
fied as a downstream effector of PI 3-kinase, which is activated
by phosphoinositide-dependent kinases secondarily to recruit-
ment of both PKB and phosphoinositide-dependent kinase to
membranes via association with the PI 3-kinase product phos-
phatidylinositol 3,4,5 trisphosphate (6). Studies of the role of
PKB in stimulation of glucose transport have produced conflict-
ing data. On the one hand, glucose uptake was increased in
3T3-L1 cells expressing constitutively active or inducible PKB
(44–47). However, expression of a dominant negative PKB
failed to block insulin-stimulated glucose uptake (48, 49). We
found no difference in levels of PKB activity in isoform-specific
immunoprecipitates or in phosphorylation of serine 473 at
early and late time points, in TIR and TIGR cells stimulated
with NT-3 (Figs. 7 and 8), despite the substantial difference in
IRS-1-associated p85 and PI 3-kinase activity at the same NT-3
concentration. It may be that a small activation of PI 3-kinase
is sufficient for maximum activation of PKB or that the IRS-1-
associated pool of PI 3-kinase does not have as much influence
on PKB activity as the anti-phosphotyrosine-precipitable pool.
Regardless of the relationship between PKB and PI 3-kinase
activities, our data suggest that PKB activity alone is not the
sole determinant of stimulated glucose uptake, as identical
PKB activities were observed in TIR and TIGR cells exhibiting
significantly different stimulations of glucose uptake.
In contrast to the stimulation of glucose transport, incorpo-
ration of glucose into glycogen was stimulated to the same
maximum by NT-3 in TIR and TIGR cells, although TIR cells
were somewhat more responsive at low NT-3 concentrations
(EC50 values in the range of 0.01–0.03 nM) (Fig. 2). The dispar-
ity in NT-3 concentration dependence and fold stimulation of
glycogen synthesis compared with glucose uptake suggests that
the stimulation of synthesis reflected activation of glycogen
synthase rather than increased glucose uptake. The similar
effectiveness of IR and IGFR in stimulating glycogen synthesis
in 3T3-L1 adipocytes contrasts with the substantial difference
observed previously in 3T3-L1 fibroblasts (14). However, it has
been reported that the activation of glycogen synthase involves
predominantly inhibition of glycogen synthase kinase-3 in
3T3-L1 fibroblasts but stimulation of PP1 in adipocytes (50),
and it may be that this difference in mechanism underlies the
difference in responsiveness to IR and IGFR in the two cell
types. Like the stimulation of glucose uptake, activation of
glycogen synthase requires PI 3-kinase (30). In terms of NT-3
concentration dependence and relative effectiveness of IR and
IGFR, stimulation of glycogen synthesis correlates better with
anti-phosphotyrosine-precipitable than IRS-1-associated PI
3-kinase activity, raising the possibility that separate pools of
PI 3-kinase are involved in stimulation of glucose uptake and
glycogen synthase. Certainly, the signaling pathways to
GLUT4 translocation and glycogen synthase activation appear
to diverge downstream of PI 3-kinase. PKB has been proposed
as the principal route to inactivation of glycogen synthase
kinase-3, which in turn is thought to be the major mechanism
of activation of glycogen synthase in many tissues (51). How-
ever, in 3T3-L1 adipocytes, levels of glycogen synthase kinase-3
are low, and glycogen synthesis is not activated by constitu-
tively active PKB (44, 46). There is evidence that p70S6 kinase
contributes to activation of glycogen synthase in 3T3-L1 adipo-
cytes (31). Consistent with the similar stimulations of glycogen
synthesis mediated by TIR and TIGR, we found no difference
between the chimeras with respect to the activation of p70S6
kinase.
It seems clear, therefore, that the contribution of different
signaling pathways to end point responses may vary not only
with respect to different responses in a given cell but also with
respect to a given response in different cell types. Against this
background, it is difficult to predict relative efficiency of IR and
IGFR in mediating metabolic effects in other tissues based on
the present data for glucose transport in 3T3-L1 adipocytes.
Interestingly, in hepatocytes, as in 3T3-L1 fibroblasts, glycogen
synthesis was more effectively stimulated via IR than IGFR,
although both receptors mediated similar activation of PKB
(52). The insulin-specific stimulation of glycogen synthesis in
hepatocytes appeared to involve a rapamycin-sensitive
pathway.
It is not meaningful to study classical mitogenic responses
(proliferation/DNA synthesis) in a terminally differentiated
and nondividing cell line such as the 3T3-L1 adipocyte. How-
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ever, we examined various components of the MAP kinase
pathway that have been implicated in transcriptional and mi-
togenic responses in other cells (7). TIGR cells were more
responsive than TIR with regard to stimulation of Shc phos-
phorylation, association of Shc with Grb2, and activation of
MAP kinase (Figs. 4 and 8). No difference was observed in the
induction of Fra1 mRNA in TIR and TIGR cells stimulated by
a near-maximal concentration of NT-3, although it is possible
that relatively modest activation of MAP kinase is sufficient for
maximal Fra1 induction and that a differential effect of TIGR
and TIR on Fra1 mRNA might have been observed at lower
NT-3 concentrations. Because TIGR was expressed at a slightly
higher level than TIR in the cell lines studied, it cannot be
definitely concluded that the IGFR is more efficient than the IR
in phosphorylating Shc. However, the relative Shc responses do
provide excellent controls for the IRS-1 phosphorylation meas-
ured in the same cells, and the ratio of IRS/Shc phosphoryla-
tion was approximately 4-fold higher in TIR cells than in TIGR
cells across the full range of NT-3 concentrations tested.
Various mechanisms might contribute to relative specificity
in substrate phosphorylation by the IR and IGFR, including
differences in the intrinsic specificity of the tyrosine kinases
themselves (53, 54), differences in the association of substrates
with receptors via PTB or other domains (55–58), the modula-
tion of such interactions by receptor-specific adaptor proteins,
such as Grb10 (59, 60), or differences in endocytosis and sub-
sequent trafficking of receptors (61, 62). No major differences
between the two receptor kinases were apparent in the phos-
phorylation of recombinant IRS-1 in vitro (39), although this
result does not exclude possible differences in activity of recep-
tors toward IRS-1 in intact cells, where receptors and IRS-1
may be subject to regulatory phosphorylation on serine resi-
dues or modulation by other proteins. The carboxyl-terminal
domains of the IR and IGFR have been implicated in signaling
specificity (18–20), although the influence of this region must
be relatively subtle, as carboxyl-terminally truncated IR and
IGFR signal normally in at least some cell types (63, 64).
Surprisingly, the insulin receptor-related receptor, which is
more similar to IGFR than to IR in its carboxyl-terminal do-
main, signaled with similar efficiency to the IR in fibroblasts
and in 3T3-L1 cells (13). Further studies on chimeric constructs
involving exchange or mutagenesis of carboxyl-terminal or
other subdomains may help to define the residues responsible
for IR and IGFR signaling specificity.
In conclusion, our data suggest that the IR and IGFR acti-
vate a common pool of PI 3-kinase that is coupled to activation
of PKB and p70S6 kinase and to translocation of some GLUT4
glucose transporters. We propose that the IR, but not the IGFR,
activates an additional pool of PI 3-kinase, which may be IRS-
1-associated, and thereby mobilizes additional GLUT4 trans-
porters, resulting in greater stimulation of glucose uptake. The
biochemical basis of these putative discrete pools of PI 3-kinase
and their specificity in coupling to downstream responses re-
mains to be determined.
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